A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer families

By Romero Atocha  

Breast Cancer Research and Treatment, Vol. 129, Iss. 3, 2011-10 ,pp. : 939-946

Springer Publishing Company

Access to resources Recommend Favorite

PALB2 germline mutations in familial breast cancer cases with personal and family history of pancreatic cancer

By Peterlongo Paolo  

Breast Cancer Research and Treatment, Vol. 126, Iss. 3, 2011-04 ,pp. : 825-828

Springer Publishing Company

Access to resources Recommend Favorite

Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer

By Zheng Yonglan  

Breast Cancer Research and Treatment, Vol. 124, Iss. 3, 2010-12 ,pp. : 857-861

Springer Publishing Company

Access to resources Recommend Favorite

RAD51 135G>C polymorphism and breast cancer risk: a meta-analysis

By Zhou Guo-Wu  

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 529-535

Springer Publishing Company

Access to resources Recommend Favorite

RAD51 135G>C polymorphism contributes to breast cancer susceptibility: a meta-analysis involving 26,444 subjects

By Wang Zhanwei   Dong Hairong   Fu Yuanyuan   Ding Haixia  

Breast Cancer Research and Treatment, Vol. 124, Iss. 3, 2010-12 ,pp. : 765-769

Springer Publishing Company

Access to resources Recommend Favorite